NASDAQ
No price data available for this timeframe.
Evolent Health, Inc. (EVH) has a price/sales ratio of 0.24x as of Friday, May 22, 2026. This represents a 85.98% decrease compared to its 12-month average of 1.74x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.